Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis

Free Subscription 08.09.2025 1 AIDS 1 Eur J Gastroenterol Hepatol 1 J Hepatol 2 J Med Virol 4 J Viral Hepat 2 J Virol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. TODESCO E, Valantin MA, Akhavan S, Rouget R, et al
   Acute hepatitis B infections among PWH treated with 2-drug regimen: can we trust the vaccination status?
   AIDS. 2025;39:1845-1847.
   PubMed        
   
   

   
   Eur J Gastroenterol Hepatol

2. CHON YE, Lee J, Yoon EL, Kim SS, et al
   Changes in antiviral treatment rate for hepatitis B virus before hepatocellular carcinoma diagnosis: a nationwide Korean study.
   Eur J Gastroenterol Hepatol. 2025;37:1166-1172.
   PubMed         Abstract available
   
   

   
   J Hepatol

3. DALEKOS GN, Gatselis N, Tiniakos D
   EASL CPG: Liver biopsy cannot be skipped for the diagnosis of autoimmune hepatitis.
   J Hepatol. 2025 Sep 3:S0168-8278(25)02468-7. doi: 10.1016/j.jhep.2025.
   PubMed        
   
   

   
   J Med Virol

4. KIM H, Kim JY, Choi HB, Lee JS, et al
   Antiviral Therapy Reduces Dyslipidemia and Cardiovascular Risk in Chronic Hepatitis B: TDF as the Most Effective Agent.
   J Med Virol. 2025;97:e70584.
   PubMed         Abstract available
   
   
5. ZHONG S, Zeng Z, Jin Z, Zhang L, et al
   Single-Cell Profiling of Peripheral and Intrahepatic B Cells Reveals Altered Responses and a CCR7(+) Subset Linked to Antiviral Potential in Chronic HBV Infection.
   J Med Virol. 2025;97:e70572.
   PubMed         Abstract available
   
   

   
   J Viral Hepat

6. HANDANAGIC S, Shadaker S, BaliashvilI D, Schumacher IT, et al
   Demographic and Clinical Characteristics of Patients With Hepatitis C and Hepatitis B Co-Infection, Georgia, 2017-2023.
   J Viral Hepat. 2025;32:e70067.
   PubMed         Abstract available
   
   
7. HUANG D, Zhu Z, Peng J, Zhang S, et al
   Global Trends and Health Inequalities in Acute Hepatitis E Burden: A Joinpoint Regression and Cross-Country Inequality Analysis, 1990-2021.
   J Viral Hepat. 2025;32:e70073.
   PubMed         Abstract available
   
   
8. TORGERSEN J, Smookler D, Russell R, Gasior J, et al
   Early Read-Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV Viremia.
   J Viral Hepat. 2025;32:e70066.
   PubMed         Abstract available
   
   
9. KASSA GM, Lim AG, Tamiru MT, Alamneh TS, et al
   Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review Data.
   J Viral Hepat. 2025;32:e70065.
   PubMed         Abstract available
   
   

   
   J Virol

10. HAGA Y, Babu E P, Swiderska-Syn M, Reagan EK, et al
    Hepatitis C virus modified (S)E2(F442NYT)-mRNA-LNP candidate vaccine promotes helper CXCR5(+)T cells.
    J Virol. 2025 Sep 5:e0135525. doi: 10.1128/jvi.01355.
    PubMed         Abstract available
    
    
11. SCHWOERER MP, Carver S, Cafiero TR, Joyce B, et al
    Assessment of hepatitis C virus permissiveness in iteratively genetically humanized mice.
    J Virol. 2025 Sep 3:e0079325. doi: 10.1128/jvi.00793.
    PubMed         Abstract available
    
    

    
    PLoS One

12. SONG J, Choi SJ, Kim S, Park Y, et al
    Comparative evaluation of four fully automated immunoanalyzers for the simultaneous detection of HBeAg and Anti-HBe.
    PLoS One. 2025;20:e0331381.
    PubMed         Abstract available
    
    
13. QI X, Hu Y, Jiang W
    Epidemiological trends and projections to 2035 of hepatitis B burden in China, 1990-2021.
    PLoS One. 2025;20:e0330633.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.